...
search icon
aapg-img

AAPG, Common Stock

AAPG

NMQ

$18.24

+$0.98

(5.68%)

1D

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$6.35B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
213.52K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$16.5 L
$19.37 H
$18.24

About AAPG, Common Stock

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for the treatment of small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumor, and non-Hodgkin's lymphoma. In addition, the company is developing APG-1387, a small molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection; APG-2449, an oral inhibitor of FAK, ROS1, and ALK kinases; APG-5918, an orally available and selective embryonic ectoderm development inhibitor; APG-265, a MDM2 protein degrader; and UBX1967/1325, which are Bcl-2 inhibitors. In addition, it is also involved in medical research and development; clinical development; clinical trial operation; venture capital investment; rental services; and science and technology promotion services. The company has collaboration relationships with biotechnology and pharmaceutical companies; and research institutions. Ascentage Pharma Group International was founded in 2009 and is headquartered in Suzhou, China. more

Returns

Data is not properly formatted.

Financials

Dec '20Dec '21Dec '22Dec '23
Total Revenue12.45M27.91M209.71M221.98M[{"date":"2020-12-31","value":5.61,"profit":true},{"date":"2021-12-31","value":12.57,"profit":true},{"date":"2022-12-31","value":94.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue1.97M3.33M22.00M30.54M[{"date":"2020-12-31","value":6.44,"profit":true},{"date":"2021-12-31","value":10.9,"profit":true},{"date":"2022-12-31","value":72.02,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit10.48M24.58M187.71M191.44M[{"date":"2020-12-31","value":5.48,"profit":true},{"date":"2021-12-31","value":12.84,"profit":true},{"date":"2022-12-31","value":98.05,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin84.21%88.08%89.51%86.24%[{"date":"2020-12-31","value":94.08,"profit":true},{"date":"2021-12-31","value":98.4,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.35,"profit":true}]
Operating Expenses676.39M897.75M1.06B1.09B[{"date":"2020-12-31","value":61.79,"profit":true},{"date":"2021-12-31","value":82.01,"profit":true},{"date":"2022-12-31","value":96.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(663.94M)(869.84M)(849.81M)(872.64M)[{"date":"2020-12-31","value":-66394100000,"profit":false},{"date":"2021-12-31","value":-86983500000,"profit":false},{"date":"2022-12-31","value":-84981000000,"profit":false},{"date":"2023-12-31","value":-87263600000,"profit":false}]
Total Non-Operating Income/Expense----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(675.45M)(832.25M)(887.17M)(932.86M)[{"date":"2020-12-31","value":-67544800000,"profit":false},{"date":"2021-12-31","value":-83224900000,"profit":false},{"date":"2022-12-31","value":-88717200000,"profit":false},{"date":"2023-12-31","value":-93286200000,"profit":false}]
Income Taxes----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(677.61M)(782.42M)(882.92M)(925.71M)[{"date":"2020-12-31","value":-67760600000,"profit":false},{"date":"2021-12-31","value":-78242400000,"profit":false},{"date":"2022-12-31","value":-88292400000,"profit":false},{"date":"2023-12-31","value":-92571200000,"profit":false}]
Income From Discontinued Operations----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(677.61M)(782.42M)(882.92M)(925.64M)[{"date":"2020-12-31","value":-67760600000,"profit":false},{"date":"2021-12-31","value":-78242400000,"profit":false},{"date":"2022-12-31","value":-88292400000,"profit":false},{"date":"2023-12-31","value":-92563700000,"profit":false}]
EPS (Diluted)----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AAPG
Current Ratio 1.84
Quick Ratio 1.83

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AAPG
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AAPG
Debt Ratio Lower is generally better. Negative is bad. 0.75
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.25

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AAPG
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is AAPG share price today?

AAPG (AAPG) share price today is $18.24

Can Indians buy AAPG shares?

Yes, Indians can buy shares of AAPG (AAPG) on Vested. To buy AAPG from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AAPG stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of AAPG be purchased?

Yes, you can purchase fractional shares of AAPG (AAPG) via the Vested app. You can start investing in AAPG (AAPG) with a minimum investment of $1.

How to invest in AAPG shares from India?

You can invest in shares of AAPG (AAPG) via Vested in three simple steps:

  • Click on Sign Up or Invest in AAPG stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in AAPG shares
What is AAPG 52-week high and low stock price?

The 52-week high price of AAPG (AAPG) is $19.37. The 52-week low price of AAPG (AAPG) is $16.5.

What is AAPG price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of AAPG (AAPG) is 0.00

What is the Market Cap of AAPG?

The market capitalization of AAPG (AAPG) is $6.35B

What is AAPG’s stock symbol?

The stock symbol (or ticker) of AAPG is AAPG

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top